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Abstract 
Aims: Hepatic progenitor cells (HPCs) are activated in various liver diseases but 
their role in carcinomatous environment remains unknown. We aimed to identify the 
possible presence and topography of HPCs in liver metastases. 
Methods: We examined 14 liver resection specimens for colorectal adenocarcinoma 
(CRC) (n=13) and anal squamous cell carcinoma (SCC) (n=1) metastases. 
Immunohistochemical markers of colonic (keratin 20-K20, CDX2) and squamous cell 
origin (p63), HPC (K19, CD56) and stem cell (CD44) markers, and the biliary marker 
K7 which may also highlight HPCs were applied on routinely processed tissue 
sections. Double immunohisto- chemistry/immunofluorescence (K7/CDX2) and 
confocal microscopy were used on selected sections. 
Results: K7-, Κ19- and CD56-positive ductular structures were encountered within 
the metastatic tumour (tumour interior and periphery), and in the immediate 
peritumoural area. Hybrid structures composed of HPCs and metastatic 
adenocarcinoma cells were recognised and confirmed by double immunostaining 
(K7/CDX2). Carcinoma cells were also observed singly or in groups within the 
epithelium of interlobular bile ducts and/or ductules in portal tracts without evidence 
of carcinomatous infiltration and at a distance from the metastatic foci. 
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 Conclusions: HPCs are observed at the periphery and the interior of liver 
metastatic carcinomas. Bile ductules and small interlobular bile ducts may attract 
carcinoma cells serving as potential “metastatic niche”, in line with their recognised 
role as HPC niches in non-neoplastic liver.   
 
Key words: hepatic progenitor cells, liver metastasis, ductular reaction, metastatic 
niche, metastatic carcinoma 
 
Introduction  
The hepatic progenitor cells (HPC) compartment comprises a spectrum of subtypes 
of variable differentiation including isolated progenitor cells and string-like ductular 
structures (DS) at the portal/parenchymal interface known as ductular reaction.1,2 
Intermediate hepatocytes, keratin 7 (K7)-positive hepatocytes and bile ductules are 
more differentiated forms of increasing maturity. The HPC immunophenotype 
includes hepatocytic, cholangiocellular, hepatoblast, and hematopoietic stem cell 
markers. 3-6 
  Sufficient data suggest that adult HPCs may also derive from mature 
hepatocytes through a dedifferentiation process in the context of acute and chronic 
liver injury.7-9 Hepatocyte loss in association with impaired hepatocyte regenerative 
capacity, replicative exhaustion and senescence are triggering factors for an 
alternative regeneration pathway involving HPCs.1,5,7 In contrast, the functional role 
of HPCs in primary and metastatic liver carcinoma still remains unknown. We aimed 
to explore the presence and topography of HPCs in metastatic liver carcinomas. 
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Patients and Methods 
The presence of HPCs was examined in 13 specimens of liver metastasectomies 
(segmental hepatectomies n=10, left hepatectomies n=2, right hepatectomy n=1) for 
colorectal adenocarcinoma (CRC) and a metachronous solitary liver metastasis of 
anal squamous cell carcinoma (SCC) which was removed by segmental 
hepatectomy.  
Metastatic adenocarcinomas were selected from a total of 60 cases of liver 
CRC metastasis resected between 2007 and 2014 according to the following 
inclusion criteria: a) metastatic CRC excised concurrently with the resection of the 
primary tumour, b) no pre-operative neo-adjuvant chemotherapy, c) primary CRC 
immunophenotype different from that of HPC, biliary epithelial cells and hepatocytes 
[CDX2/keratin 20 (K20) positive and keratin 7(K7)/CD56/HepPar-1 negative]. All 
primary carcinomas and their metastatic foci were of moderate histological 
differentiation and four showed extensive necrosis. Informed consent was obtained 
from each patient prior to surgery for use of surplus diagnostic material for research 
purposes. The study protocol conforms to the ethical guidelines of the 1975 
Declaration of Helsinki.  
Immunohistochemical examination of serial paraffin sections included stains for 
K20 and CDX2 (CRC markers); K19 and CD56 (HPC markers); CD44 (stem cell 
marker) and K7 (biliary marker that also highlights HPCs). In the metastatic anal 
SCC, p63 was used as nuclear marker for the identification of SCC tumour cells. 
Double immunostaining was performed using K7 and CDX2 in CRC metastases. 
Additionally, double immunofluorescence for K7 and CDX2 was performed in 
selected sections evaluated by confocal microscopy. Keratin 19 was not used as 
HPC marker in the double immunostaining experiments because it may be 
expressed by CRC cells.  
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The presence of HPC subtypes was examined within the metastatic tumour 
(tumour interior and periphery), in the immediate peritumoural area (one low power 
field x10) and in the adjacent non-neoplastic liver tissue (tumour periphery and 
peritumoural area are depicted in Supplementary Figure 1). One representative 
section from each case was examined and the density of HPC subtypes was 
assessed semi-quantitatively. Ductular reaction at the portal/parenchymal interface of 
non-neoplastic liver tissue was recorded.  
Details on antibodies and methodology can be found in Supporting Information 
file 1. 
 
Results 
In all cases, a variable number of K7-positive and CD56-positive DS and mature 
ductules were encountered in the immediate peritumoural area, while ductular 
reaction constituted a rather common finding in the neighbouring non-neoplastic liver. 
DS were also discernible at the periphery and less frequently in the interior of 
carcinomatous foci both in the stroma and the epithelial component (Figure 1A). K20, 
CDX2 and p63 were negative in DS. In contrast, carcinoma cells did not exhibit HPC 
markers and were immunostained diffusely for K20 and CDX2 in metastatic CRC foci 
and for p63 in metastatic SCC. CD44-positive cells were rarely encountered. 
HepPar-1-positive hepatocytes were visible, usually in small groups, in the 
peritumoural stroma while only few entrapped atrophic HepPar-1-positive 
hepatocytes were still visible at the tumour periphery. 
In all metastatic CRC cases, examination of immunostained serial sections at 
high magnification revealed HPCs adherent to carcinoma cells, creating hybrid 
structures of combined HPC/carcinomatous composition. This phenomenon was 
evident by the differences in cell morphology and immunophenotype between HPCs 
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and carcinoma cells (Figures 1B, 1C, 1D).  HPCs were small-sized, flat with oval 
nuclei without atypia while the carcinoma cells were larger, cuboidal or cylindrical 
with atypical nuclei. HPCs exhibited a typical immunohistochemical profile (K7, CD56 
positive and K20, CDX2 negative) in contrast to carcinoma cells which stained 
positively only for CRC markers (K20 and CDX2) or p63. Immunohistochemical 
investigation also revealed solitary HPCs among carcinoma cells.   
The aforementioned observations were confirmed by double K7/CDX2 
immunofluorescence assessed by confocal microscopy (Figures 1E & 1F and 
Supplementary Figure 2) and double K7/CDX2 immunostaining (Supplementary 
Figure 3) that highlighted the dual nature of the hybrid tubular structures and the 
structural co-existence of the different cell types. No cells were identified co-
expressing K7/CDX2.  
In the single anal SCC metastasis case, intratumoural HPCs were 
encountered as isolated cells within carcinoma sheets recognized by their typical 
immunoprofile in contrast to p63-positive anal SCC cells.  
In six CRC cases and in the anal SCC case, K20- and p63-positive carcinoma 
cells, single or in small groups, were seen in interlobular ducts and ductules located 
in portal tracts at a distance from the periphery of the tumours (Figure 2). There were 
no signs of invasion of the intervening non-neoplastic liver tissue or in the portal tract 
stroma, neither disruption of the basement membrane of the involved ducts and 
ductules. 
Supporting Information file 2 shows detailed immunohistochemical results for 
each hepatic CRC metastasis case. 
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Discussion  
HPCs disclose features of stemness represented by their multilineage differentiation 
capacity, their ability to migrate and their involvement in carcinogenesis.10 
Hepatic stem/progenitor cells give rise to carcinomas with stem cell features 
and their subtypes,11 while retrodifferentiation of hepatocellular carcinoma (HCC) 
cells induced in vitro by inflammatory cytokines is implicated as an additional 
carcinogenic pathway.12 In vitro and in vivo models in a single study13 suggest that 
HPCs may have a marked effect on HCC cells and appear to stimulate the growth 
and malignant potential of experimental HCC tumours. In respect to the spatial 
relationship of HPCs and tumour tissue, oval cells localized inside and outside the 
carcinomatous foci have been observed in rats,14 while HPCs have very occasionally 
been reported in human hepatocellular tumours.15,16 
         Our study is the first to highlight the existence of HPCs within metastatic 
liver carcinomas, usually in the form of DS. They were encountered in the 
newly formed peritumoural and intratumoural stroma, as well as within the 
carcinomatous epithelial component. The most impressive finding was their 
presence in hybrid tubular structures of mixed HPC/carcinoma cell 
composition. The detection of HPCs was facilitated by their specific 
morphology and immunoprofile in combination with the absence of CRC cell 
markers K20, CDX2 and the SCC marker p63, and was confirmed by double 
immunostaining (K7 and CDX2) and double immunofluorescence (K7 and 
CDX2). Various hypotheses may explain this phenomenon.  Activation of 
HPCs originating from entrapped non-neoplastic ductules and small ducts or 
HPC migration in the metastatic foci under the influence of chemoattractants 
are plausible explanations. Regarding the hybrid structures, they may present 
the end-product of DS contact with carcinomatous elements by creating new 
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HPC-carcinoma cell adhesions or may derive from DS infiltration by 
carcinoma cells. 
Another unique observation was the detection of carcinoma cells singly or in 
groups within interlobular bile ducts and/or ductules at a distance from the main 
tumour mass in the absence of portal tract invasion. Colonisation of major and minor 
bile ducts and intrabiliary growth has long been recognised.17,18 However, it has not 
been clarified whether this phenomenon may be attributed to bile duct invasion from 
a parenchymal metastatic focus or whether it represents a genuine intrabiliary 
metastasis. The presence of single carcinoma cells within the ductular epithelium is 
indicative of a metastatic process.  
What seems to be undisputable in our study is the occasional symbiosis of 
benign HPCs and biliary epithelial cells with malignant cells, in metastatic liver 
carcinomas. This phenomenon can be ascribed to the stem cell properties shared by 
both HPCs and possible cancer stem cells. Endowed with growth factors and 
cytokines (e.g. lymphotoxin-b, MCP-1, PDGF, TGF-β),19-23 HPCs participate in 
fibrogenesis and liver cell regeneration and may potentially contribute to tumour 
growth and stroma formation adapting a role similar to that of bone marrow stem 
cells in the expansion of primary and metastatic carcinomas.24 On the other hand, it 
is reasonable to assume that cytokines, growth factors and chemokines produced by 
tumour stroma and carcinoma cells may activate and attract HPCs.  It is well known, 
that HPCs require essential pro-inflammatory cytokines and growth factors, 
analogous to those produced by carcinoma cells to proliferate and differentiate.25 
Lastly, the colonisation of small bile ducts and ductules by carcinoma cells highlights 
a potential metastatic niche that already functions as a suitable microenvironment for 
non-neoplastic HPCs.  
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 Limitations of our study include the small but representative number of cases 
and the examination of only two types of metastatic liver cancer in the context of an 
observational study. It may be argued that the individual immunohistochemical 
markers used to support or exclude CRC, SCC or HPC origin are not 100% specific 
or sensitive. However, when these markers are jointly assessed in conjunction with 
careful morphological examination their application is appropriate for the purpose of 
our study. 
 In conclusion, our morphological and immunohistochemical study 
provides strong indications of HPC presence within metastatic liver 
carcinomas, usually in the form of immature DS. Bile ductules and small 
interlobular bile ducts may attract carcinoma cells serving as a possible 
“metastatic niche” in line with their recognised role as HPC niche in non-
neoplastic liver. The role and fate of intracancerous HPCs remains unknown 
requiring clarification in future in-depth investigations at a molecular level. 
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Figure legends 
Figure 1: A. Entrapment of ductular structures (DS) within the tumour tissue 
(K7 immunostain, DAB chromogen, x200). B. Hybrid structures composed of 
CRC cells (K7-) and HPCs (K7+) (K7 immunostain, DAB chromogen, x400). 
C. Hybrid structures composed of K20+ CRC cells and K20- HPC (K20 
immunostain, DAB chromogen, x400).  D. Hybrid structures composed of 
CRC cells (CD56-) and HPCs (CD56+) (CD56 immunostain, DAB chromogen, 
x400). E, F. Double K7/CDX2 immunofluorescence assessed by confocal 
microscopy highlights hybrid structures composed of K7+ (green) HPC and 
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CDX2+ (red) CRC cells (merged with nuclear DAPI counterstaining (blue) E 
x540, F x920).  
 
Figure 2: Carcinoma cells within the epithelium of interlobular bile ducts and 
ductules (circles) in portal tracts at a distance from the periphery of the tumour 
mass. Α. K20+ CRC tumour cells (K20 immunostain, DAB chromogen, x400). 
B. K7+ bile ductal epithelium, K7- CRC tumour cells (K7 immunostain, DAB 
chromogen, x200). C. p63+ SCC tumour cells (p63 immunostaining, DAB 
chromogen, x100). 
 
Supplementary Figure legends: 
Supplementary Figure 1: Tumor periphery (encircled) and immediate 
peritumoural area (K7 immunostain, DAB chromogen, x200). 
  
Supplementary Figure 2: Decomposed Figures 1E and 1F showing merged K7 
(green)/CDX2 (red) and non-merged K7 (green), CDX2 (red) and DAPI (blue) 
immunofluorescence.  
 
Supplementary Figure 3: Hybrid structures (arrows) composed of K7+/CDX2- HPC 
and K7-/CDX2+ CRC cells [double K7/CDX2 immunostaining with cytoplasmic K7 
(AEC chromogen) and nuclear CDX2 (DAB chromogen), x400]. 
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